Veracyte (VCYT) Total Non-Current Liabilities (2012 - 2026)
Veracyte (VCYT) posted Total Non-Current Liabilities of $91.7 million for Q1 2026, down 3.29% sequentially from $94.9 million in Q4 2025, and down 23.49% YoY from $119.9 million in Q1 2025.
Veracyte (VCYT) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends
Veracyte (VCYT) has 11 years of Total Non-Current Liabilities data on file, last reported at $91.7 million in Q1 2026.
- Quarterly Total Non-Current Liabilities fell 23.49% year-over-year to $91.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $91.7 million (down 23.49% YoY) and the FY2025 annual result came in at $94.9 million, down 23.29% from the prior year.
- Total Non-Current Liabilities eased to $91.7 million in Q1 2026 per VCYT's latest filing, from $94.9 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $123.7 million in Q4 2024, with the low at $70.0 million in Q4 2023.
- Average Total Non-Current Liabilities over 5 years is $90.5 million, with a median of $84.8 million recorded in 2024.
- Year-over-year, Total Non-Current Liabilities jumped 77.21% in 2022 and fell 23.49% in 2026.
- Veracyte's Total Non-Current Liabilities stood at $80.3 million in 2022, then dropped by 12.79% to $70.0 million in 2023, then soared by 76.61% to $123.7 million in 2024, then slipped by 23.29% to $94.9 million in 2025, then retreated by 3.29% to $91.7 million in 2026.
- Business Quant data shows VCYT's Total Non-Current Liabilities at $91.7 million in Q1 2026, $94.9 million in Q4 2025, and $109.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn | 91.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.74 Mn |
| Dec 31, 2025 | 94.85 Mn |
| Sep 30, 2025 | 109.54 Mn |
| Jun 30, 2025 | 122.47 Mn |
| Mar 31, 2025 | 119.91 Mn |
| Dec 31, 2024 | 123.66 Mn |
| Sep 30, 2024 | 84.75 Mn |
| Jun 30, 2024 | 99.60 Mn |
| Mar 31, 2024 | 80.90 Mn |
| Dec 31, 2023 | 70.02 Mn |
| Sep 30, 2023 | 70.11 Mn |
| Jun 30, 2023 | 73.54 Mn |
| Mar 31, 2023 | 75.07 Mn |
| Dec 31, 2022 | 80.29 Mn |
| Sep 30, 2022 | 76.63 Mn |
| Jun 30, 2022 | 77.69 Mn |
| Mar 31, 2022 | 87.02 Mn |
| Dec 31, 2021 | 85.59 Mn |
| Sep 30, 2021 | 77.39 Mn |
| Jun 30, 2021 | 51.79 Mn |